The 2022 AACR annual meeting has delivered a wealth of new data and analysis regarding the most cutting-edge drugs and clinical trials. At Beacon Cytokine, we have identified all cytokine-relevant abstracts released so far for AACR 2022, and extracted all the key data onto their respective drug and clinical trial pages on our database. With so much information available, Beacon Cytokine provides a valuable tool to accurately track developments in this fast-moving landscape.
Summary insights for cytokine development at AACR 2022:
- 121 cytokine-relevant abstracts were identified from AACR 2022
- 87 of these abstracts contained preclinical data for 94 different cytokine drugs
- 33 of these abstracts contained clinical data for 33 different clinical trials involving cytokine drugs
- Interleukin drugs are the focus of 59% of these abstracts
Find out more
This insight and data is part of the subscription to Beacon Cytokine.
Speak with our Team
Our dedicated team is on hand to showcase how Beacon can help you find the answers to your cytokine questions.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements